[1]
|
J. M. Connor and D. A. Evans, “Fibrodysplasia Ossificans Progressiva: The Clinical Features and Natural History of 34 Patients,” Journal of Bone and Joint Surgery of Britain, Vol. 64, No. 1, 1982, pp. 76-83.
|
[2]
|
G. Feldman, M. Li, S. Martin, M. Urbanek, J. A. Urtizberea, M. Fardeau, M. LeMerrer, J. M. Connor, J. M. Triffitt, R. Smith, M. Muenke, F. S. Kaplan and E. M. Shore, “Fibrodysplasia Ossificans Progressiva, a Heritable Disorder of Severe Heterotopic Ossification, Maps to Human Chromosome 4q27-31,” American Journal of Human Genetics, Vol. 66, 2000, pp. 128-135.
doi:10.1086/302724
|
[3]
|
F. H. Gannon, B. A. Valentine, E. M. Shore, M. A. Zasloff and F. S. Kaplan, “Acute Lymphocytic Infiltration in an Extremely Early Lesion of Fibrodysplasia Ossificans Progressiva,” Clinical and Orthopedic Related Research, Vol. 346, 1998, pp. 19-25.
doi:10.1097/00003086-199801000-00005
|
[4]
|
A. B. Shafritz, E. M. Shore, F. H. Gannon, M. A. Zasloff, R. Taub, M. Muenke and F. S. Kaplan, “Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans Progressiva,” New England Journal of Medicine, Vol. 22, 1996, pp. 555-561. doi:10.1056/NEJM199608223350804
|
[5]
|
E. A. Olmsted, F. S. Kaplan and E. M. Shore, “Bone Morphogenic Protein-4 Regulation in Fibrodysplasia Ossificans Progressiva,” Clinical and Orthopedic Related Research, Vol. 408, 2003, pp. 331-343.
doi:10.1097/00003086-200303000-00044
|
[6]
|
L. S. de la Pena, P. C. Billings, J. L. Fiori, J. Ahn, F. S. Kaplan and E. M. Shore, “Fibrodisplasia Ossificans Progressiva (FOP), a Disorder of Ectopic Osteogenesis, Mis-Regulates Cell Surface Expression and Trafficking BMPRIA,” Journal of Bone and Mineral Research, Vol. 20, No. 7, 2005, pp. 1168-1176. doi:10.1359/JBMR.050305
|
[7]
|
E. M. Shore, M. Xu, G. J. Feldman, D. A. Fenstermacher, T. J. Cho, I. H. Choi, J. M. Connor, P. Delai, D. L. Glaser, M. LeMerrer, R. Morhart, J. G. Rogers, S. Roger, J. T. Triffitt, J. A. Urtizberea, M. Zasloff, M. A. Brown and F. S. Kaplan, “A Recurrent Mutation in the BMP Type I Receptor ACVR1 Causes Inherited and Sporadic Fibrodysplasia Ossificans Progressiva,” Nature Genetics, Vol. 38, 2006, pp. 525-527. doi:10.1038/ng1783
|
[8]
|
G. Li, H. Peng, K. Corsi, A. Usas, A. Olshanski and J. Huard, “Differential Effect of BMP4 on NIH/3T3 and C2C12 Cells: Implications for Endochondral Bone Formation,” Journal of Bone and Mineral Research, Vol. 20, No. 9, 2005, pp. 1611-1623. doi:10.1359/JBMR.050513
|
[9]
|
I. Hisa, Y. Inoue, G. N. Hendy, L. Canaff, R. Kitazawa, S. Kitazawa, T. Komori, T. Sugimoto, S. Seino and H. Kaji, “Parathyroid Hormone-Responsive Smad3-Related Factor, Tmem119, Promotes Osteoblast Differentiation and Interacts with the Bone Morphogenetic Protein-Runx2 Pathway,” Journal of Biological Chemistry, Vol. 286, 2011, pp. 9787-9796. doi:10.1074/jbc.M110.179127
|
[10]
|
J. M. Wozney, V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick and E. A. Wang, “Novel Regulators of Bone Formation: Molecular Clones and Activities,” Science, Vol. 242, No. 4885, 1988, pp. 1528-1534. doi:10.1126/science.3201241
|
[11]
|
E. Canalis, A. N. Economides and E. Gazzerro, “Bone Morphogenetic Proteins, Their Antagonists, and the Skelton,” Endocrine Reviews, Vol. 24, No. 2 2003, pp. 218-235. doi:10.1210/er.2002-0023
|
[12]
|
S. Epstein, A. M. Inzerillo, J. Caminis and M. Zaidi, “Disorders Associated with Acute Rapid and Severe Bone Loss,” Journal of Bone and Mineral Research, Vol. 18, No. 12, 2003, pp. 2083-2094.
doi:10.1359/jbmr.2003.18.12.2083
|
[13]
|
E. Canalis and A. Giustina, “Glucocorticoid-Induced Osteoporosis: Summary of a Workshop,” Journal of Clinical Endocrinology & Metabolism, Vol. 86, No. 12, 2001, pp. 5681-5685. doi:10.1210/jc.86.12.5681
|
[14]
|
M. Kanatani, T. Sugimoto, H. Kaji, T. Kobayashi, K. Nishiyama, M. Fukase, M. Kumegawa and K. Chihara, “Stimulatory Effect of Bone Morphogenetic Protein-2 on Osteoclast-Like Cell Formation and Bone Resorbing Activity,” Journal of Bone and Mineral Research, Vol. 10, No. 11, 1995, pp. 1681-1690. doi:10.1002/jbmr.5650101110
|
[15]
|
H. Kaneko, T. Arakawa, H. Mano, T. Kaneda, A. Ogasawara, M. Nakagawa, Y. Toyama, Y. Yabe, M. Kumegawa and Y. Hakeda, “Direct Stimulation of Osteoclastic Bone Resorption by Bone Morphognetic Protein (BMP)-2 and Expression of BMP Receptors in Mature Osteoclasts,” Bone, Vol. 27, No. 24, 2000, pp. 479-486.
doi:10.1016/S8756-3282(00)00358-6
|
[16]
|
M. Okamoto, J. Murai, H. Yoshikawa and N. Tsumaki, “Bone Morphogenetic Proteins in Bone Stimulate Osteoclasts and Osteoblasts during Bone Development,” Journal of Bone and Mineral Research, Vol. 21, No. 7, 2006, pp. 1022-1033. doi:10.1359/jbmr.060411
|
[17]
|
Y. Miyachi, H. Yotsumoto, T. Kano, A. Mizuchi, T. Muto and L. Yanagibashi, “Blood Levels of Synthetic Glucocorticoids after Administration by Various Routes,” Journal of Endocrinology, Vol. 82, 1978, pp. 149-157.
doi:10.1677/joe.0.0820149
|